Sourcing Exosomes in Massachusetts

ExaVeyra ships to licensed practices in all 50 states, Massachusetts included. Distribution-side licensing is the supplier’s obligation rather than the purchasing practice’s, so your practice orders against its own professional license and NPI, and ExaVeyra confirms the destination-specific licensure of its supply chain before a first order ships. What changes state to state is how the state regulates who performs a procedure and how the practice itself is licensed, while federal law governs the product itself.

What your practice provides

• An active Massachusetts professional license in good standing, verifiable through the Board of Registration in Medicine, the Board of Registration in Nursing or the Board of Registration of Physician Assistants.
• A valid NPI, which ExaVeyra verifies at account setup.
• A signed research-use acknowledgment on file for exosome material.
• A Massachusetts Sales Tax Resale Certificate (Form ST-4) under 830 CMR 64H.8.1 if the practice is purchasing for resale rather than for use in its own operations.

How the state permits wholesale distribution

Massachusetts licenses the out-of-state supplier through the Board of Registration in Pharmacy. M.G.L. c. 112, § 39J directs the board to license non-resident pharmacies that ship, mail, sell or dispense medications in the commonwealth, and provides that no pharmacy operating outside the state may ship, sell or dispense drug preparations in Massachusetts unless they were produced in a pharmacy holding a non-resident license. Section 36B requires a wholesale druggist license, issued per location and renewed annually, of anyone engaged in the wholesale drug business, and 247 CMR 7.00 implements the federal Prescription Drug Marketing Act’s rule that a wholesale distributor of prescription drugs be licensed in each state where it distributes. Section 39G adds a retail sterile compounding pharmacy license, held to current USP standards and inspected before renewal, for pharmacies that compound sterile preparations. Separately, the Department of Public Health treats every prescription drug as a controlled substance for registration purposes under M.G.L. c. 94C, and its published policy is that a distributor outside Massachusetts whose only in-state activity is direct delivery to a registered entity does not need a Massachusetts controlled substances registration. Each license sits with the supplier, not with the purchasing practice.

M.G.L. c. 112, §§ 36B, 39G, 39J; 247 CMR 6.00, 7.00 · Massachusetts Board of Registration in Pharmacy

Massachusetts spreads the rules across three boards rather than one statute. Physician delegation to a physician assistant runs on the § 9E supervision standard; nursing practice runs on orders and on the nursing board’s advisory rulings; and a nurse practitioner with independent practice authority under § 80E orders within nursing scope on their own. On top of the practice acts sits clinic licensure: unless the entity is wholly practitioner-owned and controlled, the Department of Public Health licenses it as a clinic and inspects it against 105 CMR 140.000.

Good faith examination

Massachusetts does not use the phrase “good faith examination” as a statutory term. The functional requirement follows from the scope rules: a practitioner who may diagnose and prescribe, meaning a physician, a physician assistant under supervision or a nurse practitioner within § 80E, evaluates the patient and issues the order, and a registered nurse carries out the order without selecting the medication, device or setting. Confirm current expectations with the Board of Registration in Medicine and the Board of Registration in Nursing.

Ownership and clinic licensing

Massachusetts reaches practice ownership through clinic licensure rather than a corporate practice statute. Under M.G.L. c. 111, § 51 the Department of Public Health licenses clinics, and § 52 defines a clinic as any entity, however organised, maintained to provide ambulatory medical services, while exempting a solo or group practice wholly owned and controlled by its practitioners that does not use the words clinic, institute or dispensary in its name. The Department’s 2013 medical spa advisory applies that rule directly: an establishment offering laser, light or radiofrequency devices, chemical peels, soft tissue fillers, botulinum toxin, sclerotherapy or any procedure using a biologic or synthetic material is providing medical services and is subject to clinic licensure under 105 CMR 140.000 unless it is wholly owned and controlled by the practitioners providing them. Structure the entity with Massachusetts counsel before opening.